Research output per year
Research output per year
Fingerprint
Dive into the research topics where Charlie Lees is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Real-world effectiveness of upadacitinib in Crohn’s disease: a UK multicentre retrospective cohort study
Elford, A. T., Bishara, M., Plevris, N., Gros, B., Constantine-Cooke, N., Goodhand, J., Kennedy, N. A., Ahmad, T. & Lees, C. W., 3 Apr 2024, In: Frontline Gastroenterology. 15, 4, p. 297-304Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Considerations for peripheral blood transport and storage during large-scale multicentre metabolome research
Alexander, J. L., Wyatt, N. J., Camuzeaux, S., Chekmeneva, E., Jimenez, B., Sands, C. J., Fuller, H., Takis, P., Ahmad, T., Doyle, J. A., Hart, A., Irving, P. M., Kennedy, N. A., Lees, C. W., Lindsay, J. O., McIntyre, R. E., Parkes, M., Prescott, N. J., Raine, T., Satsangi, J., & 6 others, 5 Jan 2024, In: Gut. 73, 2, p. 379-383 5 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Real-World Cohort Study on the Effectiveness and Safety of Filgotinib Use in Ulcerative Colitis
Gros, B., Goodall, M., Plevris, N., Constantine-Cooke, N., Elford, A. T., O'Hare, C., Noble, C. L., Jones, G. R., Arnott, I. D. & Lees, C. W., 8 Dec 2023, In: Journal of Crohn's and Colitis.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Longitudinal Fecal Calprotectin Profiles Characterize Disease Course Heterogeneity in Crohn's Disease
Constantine-Cooke, N., Monterrubio-Gómez, K., Plevris-Papaioannou, N., Derikx, L. A. A. P., Gros, B., Jones, G-R., Marioni, R. E., Lees, C. W. & Vallejos, C. A., 31 Mar 2023, (E-pub ahead of print) In: Clinical Gastroenterology and Hepatology.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti-TNF Therapy (IMSAT) therapeutic drug monitoring study
Chanchlani, N., Lin, S., Auth, M. K., Lee, C. L., Robbins, H., Looi, S., Murugesan, S. V., Riley, T., Preston, C., Stephenson, S., Cardozo, W., Sonwalkar, S. A., Allah‐ditta, M., Mansfield, L., Durai, D., Baker, M., London, I., London, E., Gupta, S., Di Mambro, A., & 81 others, 29 Aug 2022, In: Alimentary Pharmacology and Therapeutics. 56, 8, p. 1250-1263Research output: Contribution to journal › Article › peer-review
Open AccessFile
-
FLF 3 Year Extension: Predicting Disease Flare And Treatment Response In Inflammatory Bowel Disease
1/11/23 → 31/10/26
Project: Research
-
Predicting disease flare and treatment response in inflammatory bowel disease
1/11/19 → 31/10/24
Project: Research
-
SARS-CoV2 Vaccination immunogenicity in Immunosuppressed inflammatory bowel disease Patients
1/07/21 → 16/05/23
Project: Research
-
Predicting disease flare and treatment response in inflammatory bowel disease
1/11/19 → 31/10/23
Project: Research
-
Investigation of biological pathways during active disease flare in IBD patients
Non-EU industry, commerce and public corporations
11/09/19 → 10/09/20
Project: Research
Press/Media
-
Dr Charlie Lees (CGEM) launches major study into Crohn’s and colitis
19/01/17
3 items of Media coverage
Press/Media: Research
-
Dr Charlie Lees attempts to explain surge in Scots’ Crohn’s Disease cases
25/01/15
3 items of Media coverage
Press/Media: Research